|
DiGiuseppe, J A; Kastan, M B; Weng, L J et al. (1999) Cytoprotective effects of hematopoietic growth factors on primary human acute myeloid leukemias are not mediated through changes in BCL-2, bax, or p21WAF1/CIP1. In Vivo 13:1-6
|
|
DiGiuseppe, J A; Weng, L J; Yu, K H et al. (1999) Phenylbutyrate-induced G1 arrest and apoptosis in myeloid leukemia cells: structure-function analysis. Leukemia 13:1243-53
|
|
Canman, C E; Kastan, M B (1998) Small contribution of G1 checkpoint control manipulation to modulation of p53-mediated apoptosis. Oncogene 16:957-66
|
|
Kirsch, D G; Kastan, M B (1998) Tumor-suppressor p53: implications for tumor development and prognosis. J Clin Oncol 16:3158-68
|
|
Metcalfe, S M; Canman, C E; Milner, J et al. (1997) Rapamycin and p53 act on different pathways to induce G1 arrest in mammalian cells. Oncogene 15:1635-42
|
|
Shim, H; Dolde, C; Lewis, B C et al. (1997) c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc Natl Acad Sci U S A 94:6658-63
|
|
Chen, C Y; Hall, I; Lansing, T J et al. (1996) Separate pathways for p53 induction by ionizing radiation and N-(phosphonoacetyl)-L-aspartate. Cancer Res 56:3659-62
|
|
Kastan, M B; Canman, C E; Leonard, C J (1995) P53, cell cycle control and apoptosis: implications for cancer. Cancer Metastasis Rev 14:3-15
|
|
Canman, C E; Gilmer, T M; Coutts, S B et al. (1995) Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev 9:600-11
|
|
Leonard, C J; Canman, C E; Kastan, M B (1995) The role of p53 in cell-cycle control and apoptosis: implications for cancer. Important Adv Oncol :33-42
|
Showing the most recent 10 out of 12 publications
